Prostate cancer screening

✍ Scribed by Ankerst, Donna Pauler et al.

Publisher: Humana Press,Springer
Year: 2009
Tongue: English
Leaves: 391
Series: Current clinical urology
Edition: 2ed.
Category: Library

No coin nor oath required. For personal study only.

✦ Synopsis

Incorporates a series of works in prostate cancer screening, ranging from the status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to research in various biomarkers, biomeasures, and risk algorithms for prostate cancer. This book covers family-based linkage analysis.

Abstract: Incorporates a series of works in prostate cancer screening, ranging from the status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to research in various biomarkers, biomeasures, and risk algorithms for prostate cancer. This book covers family-based linkage analysis

✦ Table of Contents

Content: Overview of US Prostate Cancer Trends in the Era of PSA Screening
Trends in Prostate Cancer Screening: Overview of the UK
Trends in Prostate Cancer Screening: Canada
Trends in Prostate Cancer Screening --
Overview of Europe
Evolution of Prostate-Specific Antigen for Screening
The Performance Characteristics of Prostate-Specific Antigen for Prostate Cancer Screening
The Performance of PSA for Predicting Prostate Cancer After a Prior Negative Prostate Biopsy
Subfractions and Derivatives of Total Prostate-Specific Antigen in the Early Detection of Prostate Cancer. PSA Velocity at Presentation as a Predictor of Prostate Cancer AggressivenessNomograms for Prostate Cancer
Decision Aid Criteria and Artificial Neural Networks for Optimizing Prostate Cancer Risk Prediction
Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator
Integration of Risk Assessment in Prostate Cancer Screening
Family History of Prostate Cancer During Rapidly Increasing Incidence
PSA Isoform.

📜 SIMILAR VOLUMES

Prostate Cancer Screening

📁 Prostate Cancer Screening

✍ Ruth Etzioni MD, Roman Gulati MS, Angela Mariotto PHD (auth.), Donna P. Ankerst 📂 Library 📅 2009 🏛 Humana Press 🌐 English

<p><P>More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection upd

Prostate Cancer Screening

📁 Prostate Cancer Screening

✍ Wael A. Sakr MD, Clara Ward MA (auth.), Ian M. Thompson MD, Martin I. Resnick MD 📂 Library 📅 2001 🏛 Humana Press 🌐 English

Prostate Cancer Screening

📁 Prostate Cancer Screening

✍ Ruth Etzioni MD, Roman Gulati MS, Angela Mariotto PHD (auth.), Donna P. Ankerst 📂 Library 📅 2009 🏛 Humana Press 🌐 English

[Advances in Clinical Chemistry] Volume

📁 [Advances in Clinical Chemistry] Volume 66 || PSA in Screening for Prostate Cancer

✍ Makowski, Gregory S 📂 Library 📅 2014 🏛 Academic Press,Elsevier

Prostate Cancer

📁 Prostate Cancer

✍ Vera Nelen MD (auth.), Jacob Ramon MD, Louis J. Denis MD, FACS (eds.) 📂 Library 📅 2007 🏛 Springer-Verlag Berlin Heidelberg 🌐 English

<p>Prostate cancer treatment dates back almost treatment approaches is examined in the subse- 100years. However, in an era of rapid develop- quent chapters of this volume. ments and innovations in cancer research and Te text addresses the time-honoured h- uro-oncology, there is an increasing need to

Prostate Cancer

📁 Prostate Cancer

✍ M. R. Alderson (auth.), Professor William Duncan (eds.) 📂 Library 📅 1981 🏛 Springer-Verlag Berlin Heidelberg 🌐 English

<p>In February 1980 the Royal College of Radiologists, London, held its Second Symposium on Clinical Oncology. The subject was Prostatic Cancer and this publication is based on the presen tations at this meeting by leading authorities in the United Kingdom. The principal objective of these Symposia